APRIL DAVIS: Open Payments
NPI 1639509219 · CHESHIRE, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 3 payments from 3 companies in 2025. Trend: 2023 $923 · 2024 $322 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $123 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
Products named: REXULTI, INGREZZA, AUSTEDO XR.
Industry payments across CT — which companies pay providers there.
